NCT00564941View on ClinicalTrials.gov

Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload

PHASE4CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Myelodysplastic SyndromesBeta-Thalassemia
Interventions
DRUG

deferasirox

Trial Locations (4)

Unknown

Novartis Investigative Site, Budapest

Novartis Investigative Site, Debrecen

Novartis Investigative Site, Pécs

Novartis Investigative Site, Szeged

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY